Hannes Alber

HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

Wolfgang Dichtl, Józef Dulak, Matthias Frick et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 342 citations · Full text

Medicine, Molecular Biology, Pharmacology +16

Empagliflozin in acute myocardial infarction: the EMMY trial

Dirk von Lewinski, Ewald Kolesnik, Norbert J. Tripolt et al. · European Heart Journal · 2022 · 290 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

Christoph Kaiser, S. Galatius, Paul Erné et al. · New England Journal of Medicine · 2010 · 268 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Multislice Computed Tomography for Detection of Patients With Aortic Valve Stenosis and Quantification of Severity

Gudrun Feuchtner, Wolfgang Dichtl, Guy Friedrich et al. · Journal of the American College of Cardiology · 2006 · 168 citations

Medicine, Cardiology, Radiology +14

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 148 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17